BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7651445)

  • 21. Is it Parkinson's disease?
    Hely M
    Aust Fam Physician; 1992 Oct; 21(10):1411-6. PubMed ID: 1444967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future strategies for the treatment of Parkinson's disease.
    Fahn S
    Adv Neurol; 1993; 60():636-40. PubMed ID: 8420202
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
    Dubas F; Vidailhet M; Henin D
    Rev Neurol (Paris); 1992; 148(8-9):580-5. PubMed ID: 1494735
    [No Abstract]   [Full Text] [Related]  

  • 25. Depression in multiple system atrophy and in idiopathic Parkinson's disease: a pilot comparative study.
    Pilo L; Ring H; Quinn N; Trimble M
    Biol Psychiatry; 1996 May; 39(9):803-7. PubMed ID: 8731521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and MRI correlation in multiple system atrophy].
    Negoro K; Morimatsu M
    No To Shinkei; 1994 May; 46(5):473-8. PubMed ID: 8060686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity.
    Gash DM; Rutland K; Hudson NL; Sullivan PG; Bing G; Cass WA; Pandya JD; Liu M; Choi DY; Hunter RL; Gerhardt GA; Smith CD; Slevin JT; Prince TS
    Ann Neurol; 2008 Feb; 63(2):184-92. PubMed ID: 18157908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nigral degeneration in Parkinson's disease in relation to clinical features.
    Rinne JO
    Acta Neurol Scand Suppl; 1991; 136():87-90. PubMed ID: 1801543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral and genital pain syndromes in Parkinson's disease.
    Ford B; Louis ED; Greene P; Fahn S
    Mov Disord; 1996 Jul; 11(4):421-6. PubMed ID: 8813222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease. Diagnosis and the initiation of therapy.
    Bhat V; Weiner WJ
    Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parkinson "plus"].
    Fabre N; Brefel-Courbon C; Rascol O
    Rev Prat; 1997 May; 47(10):1077-82. PubMed ID: 9208670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electro-oculogram in multiple system and late onset cerebellar atrophies.
    Arpa J; Sarriá J; Cruz-Martínez A; López-Pajares R; Ferrer T; Palomo F; Alonso M; Vivancos F; Nos J; Iváñez V
    Rev Neurol; 1995; 23(123):969-74. PubMed ID: 8556607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A 62-year-old man with familial parkinsonism with the onset at 24 years of the age].
    Takubo H; Kondo T; Mori H; Miyake T; Suda K; Yokochi M; Imai H; Mizuno Y
    No To Shinkei; 1996 Jun; 48(6):587-97. PubMed ID: 8703564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Kobari M; Fukuuchi Y; Shinohara T; Obara K; Nogawa S
    J Neurol Sci; 1995 Feb; 128(2):212-8. PubMed ID: 7738597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E; van't Hof M; Sweep F; Lenders JW; Oyen WJ; Horstink MW
    J Neurol; 2002 Sep; 249(9):1206-10. PubMed ID: 12242540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A 78-year-old man with young onset parkinsonism and sudden death].
    Miyasaka H; Mori H; Saikawa T; Shirai T; Kondo T; Imai H; Mizuno Y
    No To Shinkei; 1996 May; 48(5):487-95. PubMed ID: 8672309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.